HEMANGEOL is a prescription treatment for proliferating infantile hemangiomas that require systemic therapy. The website describes it as the first and only FDA-approved treatment for this indication. Its oral solution is formulated for babies and supplied with an oral dosing syringe and adapter; it is strawberry-vanilla flavored and is alcohol-free, sugar-free, and paraben-free. Treatment decisions and use should be guided by a healthcare professional.

The brand’s website provides information for parents and healthcare professionals about infantile hemangiomas, consultations, treatment, and important safety considerations. It also offers access to the Hemangiom’ App, a caregiver-focused digital resource for education and treatment adherence. The app is intended for caregivers aged 18 and older and does not replace medical advice or clinical decisions.

When a physician prescribes HEMANGEOL and sends the prescription to the specialty pharmacy Anovo, families are automatically enrolled in the Eton Cares Program, which offers support during treatment. A copay card and other resources are also available, subject to eligibility requirements.